Blalock Williams’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
10,290
+70
+0.7% +$71.5K 8% 2
2026
Q1
$9.4M Buy
10,220
+45
+0.4% +$45.6K 7.27% 1
2025
Q4
$10.9M Buy
10,175
+104
+1% +$99.4K 8.75% 1
2025
Q3
$7.68M Buy
10,071
+3
+0% +$2.23K 6.73% 1
2025
Q2
$7.85M Sell
10,068
-13
-0.1% -$10.1K 7.84% 1
2025
Q1
$8.33M Buy
10,081
+85
+0.9% +$70.7K 9.32% 1
2024
Q4
$7.72M Buy
+9,996
New +$8.28M 8.98% 1

Other funds holding LLY

Blalock Williams's LLY Position: Q2 2026 in Review

Blalock Williams increased its Eli Lilly (LLY) stake by 0.68% in Q2 2026, buying an estimated $71.5K and bringing the position to 10,290 shares worth $12.3M. The position accounts for 8% of the portfolio, ranked #2.

Blalock Williams first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blalock Williams held 10,290 shares of Eli Lilly worth $12.3M as of Q2 2026.
  • Blalock Williams bought 70 Eli Lilly shares in Q2 2026, an estimated $71.5K.
  • Eli Lilly made up 8% of Blalock Williams's portfolio in Q2 2026, its #2 holding.
  • Blalock Williams first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blalock Williams's 13F filing for Q2 2026, filed 7 Aug 2026.